Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
Oct. 10, 2019
Oct. 31, 2022
Stock Purchase Agreements [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Purchase price of common stock $ 30.0  
Net proceeds from common stock $ 28.0  
Stock Purchase Agreements [Member] | China Grand Pharmaceutical & Healthcare Holdings Ltd [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Sale of stock number of shares issued 454,545  
Stock Purchase Agreements [Member] | Sirtex Medical US Holdings Inc [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Sale of stock number of shares issued 90,909  
Warrant [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Number of warrant to purchase shares of common stock   75,897
Warrant [Member] | Minimum [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Warrant exercise price per share   $ 75.90
Warrant [Member] | Maximum [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Warrant exercise price per share   $ 275.00